Only Elligo Accelerates Clinical Trials Through the Intersection of Research and Healthcare
See How We Do ItProviding Direct Access to Our Network of Known Patients With Their Trusted Physicians and Clinical Trial Management Solutions
Elligo accelerates clinical trials through EHR data, our proprietary IntElligo® technology, and direct access to known, diverse patients from more than 115 hospitals and major health systems, 200 healthcare-based sites, and 100 research-based sites.
Our PatientSelect® model engages our network of networks to optimize the intersection of healthcare and research while our SiteSelect model and Research Partner Services enable sites to seamlessly participate in trials.
115 Hospitals and Major Health Systems
200 Healthcare-Based Research Sites
100 Research-Only Sites
Providing Direct Access to Our Network of Known Patients With Their Trusted Physicians and Clinical Trial Management Solutions
Elligo accelerates clinical trials through EHR data, our proprietary IntElligo® technology, and direct access to known, diverse patients from more than 115 hospitals and major health systems, 200 healthcare-based sites, and 100 research-based sites. Our PatientSelect® model engages our network of networks to optimize the intersection of healthcare and research while our SiteSelect model and Research Partner Services enable sites to seamlessly participate in trials.
A Patient-Centric Approach With Life-Changing Results
Watch Patient Stories
Watch the Story of Elligo
Clinical Research Services to Reduce Risk and Increase Certainty
600+
Sites
200k+
Physicians
1,000+
Studies Supported
80+
Sponsors/CROs Supported
30 Countries
Patient/Caregiver Travel
15+
Therapeutic Areas
Therapeutic Spotlight: Psychedelics
Working at the forefront of this exciting new field, Elligo offers a meticulously built network of psychedelic research sites, custom solutions, expert guidance, and comprehensive technology to propel your trial forward.
The Latest From Elligo
Over 1,000+ Trials Supported in Past Year
